एपीए उद्धरण

Melamed, I. R., Miranda, H., Heffron, M., & Harper, J. R. (2021). Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study. Front Immunol.

शिकागो स्टाइल उद्धरण

Melamed, Isaac R., Holly Miranda, Melinda Heffron, और Joseph R. Harper. "Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study." Front Immunol 2021.

एमएलए उद्धरण

Melamed, Isaac R., Holly Miranda, Melinda Heffron, और Joseph R. Harper. "Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study." Front Immunol 2021.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.